15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Biomea Fusion Inc, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets range widely, $5.00 to $12.00 (about 2.4x), a sign of real disagreement on valuation. The average target of $8.60 sits 588% above the current $1.25. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 5 over recent months. On the fundamentals, the Street sees revenue growth near 0% this year and 0% next, consensus EPS building from about $-0.27 next quarter toward $-1.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Biomea Fusion Inc.
As of Jul, 5 of 5 firms rate BMEA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BMEA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.27
Range $-0.34 – $-0.19 · 4 analysts · +14% YoY
Next period, 4 analysts expect Biomea Fusion Inc to earn $-0.27 a share (range $-0.34 – $-0.19), versus $-0.24 a year earlier. Full-year consensus is $-1.08, growing to $-1.10 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 4 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $0, rising to $0 next year.
Top analysts covering Biomea Fusion Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BMEA.
#1
Jonathan Wolleben
JMP Securities · Rank #38
Buy
$9.00+620.0% to target
Overall win rate
44%
+ Follow
#2
Anupam Rama
JP Morgan · Rank #62
Sell
No targeton BMEA
Overall win rate
46%
+ Follow
#3
Yigal Nochomovitz
Citigroup · Rank #131
Buy
$7.00+460.0% to target
Overall win rate
43%
+ Follow
#4
Joseph Pantginis
HC Wainwright & Co. · Rank #266
Buy
$18.00+1340.0% to target
Overall win rate
32%
+ Follow
#5
Edward Tenthoff
Piper Sandler · Rank #277
Buy
$7.00+460.0% to target
Overall win rate
29%
+ Follow
BMEA stock forecast FAQ
What is BMEA's average 12-month price target?+
The 5 analysts with a live target average $8.60 for Biomea Fusion Inc over the next 12 months, ranging from a $12.00 high to a $5.00 low.
Is BMEA stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BMEA?+
The Street-high target is $12.00 (D. Boral Capital), and the Street-low is $5.00 (Jefferies). The average of all 5 active targets is $8.60.
How many Wall Street analysts cover BMEA?+
5 analysts have an active rating on Biomea Fusion Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering BMEA?+
Among analysts who currently cover BMEA, Jonathan Wolleben of JMP Securities has the strongest overall Quantellect track record (Rank #38). Their current call is Buy with a $9.00 target.
What is Biomea Fusion Inc's projected EPS for next quarter?+
The consensus estimate is $-0.27 per share (range $-0.34 – $-0.19) across 4 analysts. Full-year EPS is projected at $-1.08, rising to $-1.10 the following year.
How much revenue is Biomea Fusion Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading BMEA lately?+
As of Jul, 5 of 5 firms rate BMEA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BMEA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
